Author:
White C L,Menghistu T,Twigger K R,Searle P F,Bhide S A,Vile R G,Melcher A A,Pandha H S,Harrington K J
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,Molecular Medicine
Reference25 articles.
1. Harrington KJ, Melcher AA, Bateman AR, Ahmed A, Vile RG . Cancer gene therapy: part 2. Candidate transgenes and their clinical development. Clin Oncol (R Coll Radiol) 2002; 14: 148–169.
2. Relph K, Harrington K, Pandha H . Recent developments and current status of gene therapy using viral vectors in the United Kingdom. BMJ 2004; 329: 839–842.
3. Harrington KJ, Nutting CM . Interactions between ionising radiation and drugs in head and neck cancer—how can we maximize the therapeutic index? Curr Opin Investig Drugs 2002; 3: 807–811.
4. Cobb LM, Connors TA, Elson LA, Khan AH, Mitchley BC, Ross WC et al. 2,4-dinitro-5-ethyleneiminobenzamide (CB1954): a potent and selective inhibitor of growth of the Walker carcinoma 256. Biochem Pharmacol 1969; 18: 1519–1527.
5. Boland MP, Knox RJ, Roberts JJ . The differences in kinetics of rat and human DT diaphorase result in a differential sensitivity of derived cell lines to CB1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide). Biochem Pharmacol 1991; 41: 867–875.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献